GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Electromedical Technologies EMED · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 5 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$41,195

FY2016FY2025

Net income

−$1.4m

FY2016FY2025

Free cash flow

−$149,340

FY2016FY2025

Shareholders' equity

−$3.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$41,195$588,365$1.3m$1.1m$907,362$737,958$829,737$675,383$857,717$915,000
Gross profit−$62,178$381,201$1.0m$888,641$708,128$543,574$591,221$484,328$660,287$724,800
Research and development—$231,434$231,434$92,299$215,320$31,600$82,849—$4,000—
Operating income−$1.0m−$1.1m−$2.1m−$1.6m−$3.8m−$3.2m−$1.7m−$280,700−$456,705−$292,500
Net income−$1.4m−$1.3m−$2.6m−$3.5m−$8.5m−$3.9m−$1.7m−$2.0m−$510,412−$213,100
Diluted earnings per share-0.00-0.00-0.01-0.02-0.16-0.18-0.10-0.13-0.03-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$860,537$529,216$748,383$1.4m$1.4m$1.4m$902,866$978,786$1.2m$1.3m
Cash and short-term investments$435,600$10,176$87,704$368,425$383,170$264,913——$27,860$144,900
Total liabilities$4.5m$4.4m$3.6m$3.6m$2.1m$2.7m$3.1m$3.0m$2.0m$1.6m
Debt$1.2m$1.6m$1.7m$2.0m$1.6m$1.4m$2.5m$2.6m$1.0m$862,800
Shareholders' equity−$3.6m−$3.8m−$2.9m−$2.2m−$722,503−$1.3m−$2.2m−$2.1m−$859,961−$325,600
Shares outstanding3,732m945m463m190m54m22m17m15m15m31m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$149,337−$112,317−$1.4m−$773,337−$1.2m−$1.3m−$280,772−$359,375−$137,926−$91,000
Capital spending−$3−$3−$149,705−$3−$3—————
Free cash flow−$149,340−$112,320−$1.6m−$773,340−$1.2m−$1.3m−$280,772−$359,375−$137,926−$91,000
Dividends paid—————−$36,433——−$24,000—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$4,087$3,849$11,744$7,785$7,147$14,519$17,950$42,526
Gross profit−$21,096$4,354−$44,476−$8,106−$7,299−$2,297−$4,340$30,645
Operating income−$252,000−$230,256−$285,446−$376,313−$105,356−$254,191−$277,108−$381,038
Net income−$333,217−$348,967−$390,940−$649,275−$107,720−$291,936$37,745−$724,643
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.000.00-0.00
Total assets$598,070$676,468$860,537$621,405$518,888$505,623$529,216$568,813
Cash and short-term investments$531$92,152$435,600$14,874$715—$10,176$34,809
Debt$1.1m$1.1m$1.1m$631,679$615,609$994,120$1.4m$1.6m
Shareholders' equity−$4.3m−$4.0m−$3.6m−$3.8m−$3.4m−$3.8m−$3.8m−$4.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-67.0%-43.8%-26.0%
Operating income-14.1%-20.3%8.5%
Net income-25.4%-17.9%11.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.7%72.0%73.4%74.4%
Operating margin-330.7%-183.8%-266.4%-178.5%
Net margin-433.9%-282.6%-444.0%-293.4%

Valuation history

At each fiscal year end

FY2025
Price to earnings-0.1
Price to sales4.5

Share price return

Finished calendar years

2025202420232022202120202019
Return51100%-26%-83%-78%-90%1093%126%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.